The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder

Life Sciences

Volumn 85, Issue 3-4, 2009, Pages 146-152

  Kim, Man Hee ^a   Lee, Geun Shik ^a   Jung, Eui Man ^a   Choi, Kyung Chul ^a   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

CaBP 9k; Calcium processing genes; Glucocorticoids; NCX1; PMCA1b; TRPV6; TRVP5

Indexed keywords

CALBINDIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PARATHYROID HORMONE RECEPTOR; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM ABSORPTION; CONTROLLED STUDY; DUODENUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; KIDNEY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ABSORPTION; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIUM; CALCIUM CHANNELS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DEXAMETHASONE; DUODENUM; GENE EXPRESSION; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MICE; MICE, INBRED ICR; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID HORMONE; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; SODIUM-CALCIUM EXCHANGER; TRPV CATION CHANNELS;

MUS;

EID: 67449138380     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.05.013     Document Type: Article

References (51)

1. Adler R.A., and Rosen C.J. Glucocorticoids and osteoporosis. Endocrinology and metabolism clinics of North America 23 (1994) 641-654
2. Akeno N., Matsunuma A., Maeda T., Kawane T., and Horiuchi N. Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. Journal of Endocrinology 164 (2000) 339-348
3. Bacskai B.J., and Friedman P.A. Activation of latent Ca2+ channels in renal epithelial cells by parathyroid hormone. Nature 347 (1990) 388-391
4. Barley N.F., Prathalingam S.R., Zhi P., Legon S., Howard A., and Walters J.R. Factors involved in the duodenal expression of the human calbindin-D9k gene. Biochemical Journal 341 Pt 3 (1999) 491-500
5. Bastl C.P., Schulman G., and Cragoe Jr. E.J. Low-dose glucocorticoids stimulate electroneutral NaCl absorption in rat colon. American Journal of Physiology 257 (1989) F1027-1038
6. Beaulieu J.F., and Calvert R. Influences of dexamethasone on the maturation of fetal mouse intestinal mucosa in organ culture. Comparative Biochemistry and Physiology A 82 (1985) 91-95
7. Besnard P., Jousset V., and Garel J.M. Additive effects of dexamethasone and calcium on the calcitonin mRNA level in adrenalectomized rats. FEBS Letters 258 (1989) 293-296
8. Carling T., Rastad J., Szabo E., Westin G., and Akerstrom G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 85 (2000) 2000-2003
9. Choi K.C., and Jeung E.B. Molecular mechanism of regulation of the calcium-binding protein calbindin-D9k, and its physiological role(s) in mammals: A review of current research. Journal of Cellular and Molecular Medicine 12 2 (2008) 409-420
10. Christakos S., Gill R., Lee S., and Li H. Molecular aspects of the calbindins. Journal of Nutrition 122 (1992) 678-682
11. Dang V.H., Nguyen T.H., Choi K.C., and Jeung E.B. A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor mediated mechanism following xenoestrogen exposure in the GH3 cell line. Toxicological Sciences 98 (2007) 408-415
12. Demay M.B., Kiernan M.S., DeLuca H.F., and Kronenberg H.M. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 8097-8101
13. Farman N. [Receptors of steroid hormones in the kidney]. Pathologie et Biologie (Paris) 36 (1988) 839-845
14. Farman N., Oblin M.E., Lombes M., Delahaye F., Westphal H.M., Bonvalet J.P., and Gasc J.M. Immunolocalization of gluco- and mineralocorticoid receptors in rabbit kidney. American Journal of Physiology 260 (1991) C226-233
15. Feher J.J., Fullmer C.S., and Wasserman R.H. Role of facilitated diffusion of calcium by calbindin in intestinal calcium absorption. American Journal of Physiology 262 (1992) C517-526
16. Hirst M., and Feldman D. Glucocorticoid regulation of 1,25(OH)2vitamin D3 receptors: Divergent effects on mouse and rat intestine. Endocrinology 111 (1982) 1400-1402
17. Hong E.J., Choi K.C., Hyun S.H., and Jeung E.B. Effects of calcitonin and parathyroid hormone on the regulation of cabindin-D9k in the uterus, placenta, and fetal membrane of rats related to blood calcium level during late gestation. Molecular Reproduction and Development 74 (2007) 1188-1197
18. Huang Y.C., Lee S., Stolz R., Gabrielides C., Pansini-Porta A., Bruns M.E., Bruns D.E., Miffin T.E., Pike J.W., and Christakos S. Effect of hormones and development on the expression of the rat 1,25-dihydroxyvitamin D3 receptor gene. Comparison with calbindin gene expression. Journal of Biological Chemistry 264 (1989) 17454-17461
19. Hurson C.J., Butler J.S., Keating D.T., Murray D.W., Sadlier D.M., O'Byrne J.M., and Doran P.P. Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis. BMC Musculoskeletal Disorder 8 (2007) 12
20. Huybers S., Naber T.H., Bindels R.J., and Hoenderop J.G. Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6. American Journal of Physiology: Gastrointestinal and Liver Physiology 292 (2007) G92-97
21. Iacopino A.M., and Christakos S. Corticosterone regulates calbindin-D28k mRNA and protein levels in rat hippocampus. Journal of Biological Chemistry 265 (1990) 10177-10180
22. Jia D., O'Brien C.A., Stewart S.A., Manolagas S.C., and Weinstein R.S. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147 (2006) 5592-5599
23. Kimberg D.V., Baerg R.D., Gershon E., and Graudusius R.T. Effect of cortisone treatment on the active transport of calcium by the small intestine. Journal of Clinical Investigation 50 (1971) 1309-1321
24. Lafage-Proust M.H., Boudignon B., and Thomas T. Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments. Joint Bone Spine 70 (2003) 109-118
25. Lee G.S., and Jeung E.B. Uterine TRPV6 expression during the estrous cycle and pregnancy in a mouse model. American Journal of Physiology: Endocrinology and Metabolism 293 (2007) E132-138
26. Lee G.S., Choi K.C., and Jeung E.B. Glucocorticoids differentially regulate expression of duodenal and renal calbindin-D9k through glucocorticoid receptor-mediated pathway in mouse model. American Journal of Physiology: Endocrinology and Metabolism 290 (2006) E299-307
27. Lee G.S., Choi K.C., Han H.J., and Jeung E.B. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-medicated regulation of calbindin-D9k gene in rat pituitary cells. Molecular and Cellular Endocrinology 277 (2007) 42-50
28. Lee G.S., Lee K.Y., Choi K.C., Ryu Y.H., Paik S.G., Oh G.T., and Jeung E.B. Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model. Journal of Bone and Mineral Research 22 (2007) 1968-1978
29. Li Y.C., Bolt M.J., Cao L.P., and Sitrin M.D. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. American Journal of Physiology: Endocrinology and Metabolism 281 (2001) E558-564
30. Liu Y., Porta A., Peng X., Gengaro K., Cunningham E.B., Li H., Dominguez L.A., Bellido T., and Christakos S. Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k. Journal of Bone and Mineral Research 19 (2004) 479-490
31. Lukert B.P., and Raisz L.G. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112 (1990) 352-364
32. Manolagas S.C., and Weinstein R.S. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. Journal of Bone and Mineral Research 14 (1999) 1061-1066
33. McLaughlin F., Mackintosh J., Hayes B.P., McLaren A., Uings I.J., Salmon P., Humphreys J., Meldrum E., and Farrow S.N. Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone 30 (2002) 924-930
34. Morris H.A., Need A.G., O'Loughlin P.D., Horowitz M., Bridges A., and Nordin B.E. Malabsorption of calcium in corticosteroid-induced osteoporosis. Calcified Tissue International 46 (1990) 305-308
35. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews 26 (2005) 662-687
36. Nijenhuis T., Hoenderop J.G., and Bindels R.J. Downregulation of Ca2+ and Mg2+ transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. Journal of the American Society of Nephrology 15 (2004) 549-557
37. Orcel P., and Krane S.M. [Secondary osteoporosis and glucocorticoid-induced osteoporosis]. Annales de Médecine Interne (Paris) 151 (2000) 497-503
38. Panda D.K., Miao D., Bolivar I., Li J., Huo R., Hendy G.N., and Goltzman D. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. Journal of Biological Chemistry 279 (2004) 16754-16766
39. Patschan D., Loddenkemper K., and Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29 (2001) 498-505
40. Popp A.W., Isenegger J., Buergi E.M., Buergi U., and Lippuner K. Glucocorticosteroid-induced spinal osteoporosis: Scientific update on pathophysiology and treatment. European Spine Journal 15 (2006) 1035-1049
41. Prummel M.F., Wiersinga W.M., Lips P., Sanders G.T., and Sauerwein H.P. The course of biochemical parameters of bone turnover during treatment with corticosteroids. Journal of Clinical Endocrinology and Metabolism 72 (1991) 382-386
42. Rabadan-Diehl C., and Aguilera G. Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C. Endocrinology 139 (1998) 3220-3226
43. Sheppard K.E., Li K.X., and Autelitano D.J. Corticosteroid receptors and 11beta-hydroxysteroid dehydrogenase isoforms in rat intestinal epithelia. American Journal of Physiology 277 (1999) G541-547
44. Shultz T.D., Bollman S., and Kumar R. Decreased intestinal calcium absorption in vivo and normal brush border membrane vesicle calcium uptake in cortisol-treated chickens: Evidence for dissociation of calcium absorption from brush border vesicle uptake. Proceedings of the National Academy of Sciences of the United States of America 79 (1982) 3542-3546
45. Song Y., Kato S., and Fleet J.C. Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. Journal of Nutrition 133 (2003) 374-380
46. Suzuki Y., Ichikawa Y., Saito E., and Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32 (1983) 151-156
47. Tinnanooru P., Dang V.H., Nguyen T.H., Lee G.S., Choi K.C., and Jeung E.B. Estrogen regulates the localization and expression of calbindin-D9k in the pituitary gland of immature male rats via the ERalpha-pathway. Molecular and Cellular Endocrinology 285 (2008) 26-33
48. Valin A., Guillen C., and Esbrit P. C-terminal parathyroid hormone-related protein (PTHrP) (107-139) stimulates intracellular Ca2+ through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells. Endocrinology 142 (2001) 2752-2759
49. van Abel M., Hoenderop J.G., and Bindels R.J. The epithelial calcium channels TRPV5 and TRPV6: Regulation and implications for disease. Naunyn-Schmiedeberg's Archives of Pharmacology 371 (2005) 295-306
50. Wang T.T., Tavera-Mendoza L.E., Laperriere D., Libby E., MacLeod N.B., Nagai Y., Bourdeau V., Konstorum A., Lallemant B., Zhang R., Mader S., and White J.H. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Molecular Endocrinology 19 (2005) 2685-2695
51. Zheng W., Xie Y., Li G., Kong J., Feng J.Q., and Li Y.C. Critical role of calbindin-D28k in calcium homeostasis revealed by mice lacking both vitamin D receptor and calbindin-D28k. Journal of Biological Chemistry 279 (2004) 52406-52413